Core Viewpoint - The study reveals that peritumoural adipose tissue (PAT) plays a significant role in promoting ferroptosis resistance in cancer cells through the suppression of ferritinophagy mediated by the metabolite 3-hydroxykynurenine (3HK) [2][3][5]. Group 1: Mechanism of Ferroptosis Resistance - PAT enhances cancer cell resistance to ferroptosis by upregulating ferritin and sequestering intracellular iron, with kynurenine (KYN) identified as the primary mediator [5]. - KYN is taken up by cancer cells and metabolized into 3HK, which directly interacts with NCOA4, inhibiting NCOA4-mediated ferritinophagy, a selective autophagy process that degrades ferritin to release free iron (Fe²⁺) [5][6]. - The inhibition of ferritinophagy by 3HK prevents the degradation of ferritin, thereby limiting the availability of free iron necessary for ferroptosis [6]. Group 2: Implications for Cancer Treatment - In mouse models, the combination of pharmacological inhibition of the KYN metabolic pathway and PD-1 blockade successfully overcame ferroptosis resistance and suppressed tumor progression [6]. - The findings highlight the potential of targeting the interaction between adipose tissue and tumors to enhance the efficacy of immunotherapy related to PAT [8]. - A related commentary in Nature Cell Biology emphasizes that the study demonstrates how PAT, through tryptophan metabolites (including KYN and 3HK), blocks NCOA4-mediated ferritinophagy, reducing active iron levels and inhibiting lipid peroxidation, thus aiding tumor evasion of ferroptosis [8].